 | • レポートコード：GIR-2104Z15260 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ゼローダのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ゼローダの種類別市場規模（500mg、150mg）、用途別市場規模（乳がん、結腸直腸がん、胃がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ゼローダの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Teva、Mylan、Hikma、Hengrui Medicine、Cipla、Reliance Group、Hetero ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：500mg、150mg ・用途別分析2016年-2026年：乳がん、結腸直腸がん、胃がん ・ゼローダの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ゼローダのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ゼローダのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ゼローダの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ゼローダの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Xeloda market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Xeloda size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Xeloda market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Xeloda market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
500 mg
150 mg
Market segment by Application can be divided into
Breast Cancer
Colorectal cancer
Stomach Cancer
The key market players for global Xeloda market are listed below:
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Xeloda Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Xeloda Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 500 mg
1.2.3 150 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Xeloda Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 Global Xeloda Market Size & Forecast
1.4.1 Global Xeloda Sales in Value (2016-2026))
1.4.2 Global Xeloda Sales in Volume (2016-2026)
1.4.3 Global Xeloda Price by Type (2016-2026) & (USD/MT)
1.5 Global Xeloda Production Capacity Analysis
1.5.1 Global Xeloda Total Production Capacity (2016-2026)
1.5.2 Global Xeloda Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Xeloda Market Drivers
1.6.2 Xeloda Market Restraints
1.6.3 Xeloda Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Xeloda Product and Services
2.1.4 Roche Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Xeloda Product and Services
2.2.4 Teva Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Xeloda Product and Services
2.3.4 Mylan Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hikma
2.4.1 Hikma Details
2.4.2 Hikma Major Business
2.4.3 Hikma Xeloda Product and Services
2.4.4 Hikma Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Hengrui Medicine
2.5.1 Hengrui Medicine Details
2.5.2 Hengrui Medicine Major Business
2.5.3 Hengrui Medicine Xeloda Product and Services
2.5.4 Hengrui Medicine Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Xeloda Product and Services
2.6.4 Cipla Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Reliance Group
2.7.1 Reliance Group Details
2.7.2 Reliance Group Major Business
2.7.3 Reliance Group Xeloda Product and Services
2.7.4 Reliance Group Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Hetero
2.8.1 Hetero Details
2.8.2 Hetero Major Business
2.8.3 Hetero Xeloda Product and Services
2.8.4 Hetero Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Xeloda Sales by Manufacturer
3.1 Global Xeloda Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Xeloda Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Xeloda
3.4 Market Concentration Rate
3.4.1 Top 3 Xeloda Manufacturer Market Share
3.4.2 Top 6 Xeloda Manufacturer Market Share
3.5 Global Xeloda Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Xeloda Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Xeloda Market Size by Region
4.1.1 Global Xeloda Sales in Volume by Region (2016-2026)
4.1.2 Global Xeloda Revenue by Region (2016-2026)
4.2 North America Xeloda Revenue (2016-2026)
4.3 Europe Xeloda Revenue (2016-2026)
4.4 Asia-Pacific Xeloda Revenue (2016-2026)
4.5 South America Xeloda Revenue (2016-2026)
4.6 Middle East and Africa Xeloda Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Xeloda Sales in Volume by Type (2016-2026)
5.2 Global Xeloda Revenue by Type (2016-2026)
5.3 Global Xeloda Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Xeloda Sales in Volume by Application (2016-2026)
6.2 Global Xeloda Revenue by Application (2016-2026)
6.3 Global Xeloda Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Xeloda Sales by Type (2016-2026)
7.2 North America Xeloda Sales by Application (2016-2026)
7.3 North America Xeloda Market Size by Country
7.3.1 North America Xeloda Sales in Volume by Country (2016-2026)
7.3.2 North America Xeloda Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Xeloda Sales by Type (2016-2026)
8.2 Europe Xeloda Sales by Application (2016-2026)
8.3 Europe Xeloda Market Size by Country
8.3.1 Europe Xeloda Sales in Volume by Country (2016-2026)
8.3.2 Europe Xeloda Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Xeloda Sales by Type (2016-2026)
9.2 Asia-Pacific Xeloda Sales by Application (2016-2026)
9.3 Asia-Pacific Xeloda Market Size by Region
9.3.1 Asia-Pacific Xeloda Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Xeloda Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Xeloda Sales by Type (2016-2026)
10.2 South America Xeloda Sales by Application (2016-2026)
10.3 South America Xeloda Market Size by Country
10.3.1 South America Xeloda Sales in Volume by Country (2016-2026)
10.3.2 South America Xeloda Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Xeloda Sales by Type (2016-2026)
11.2 Middle East & Africa Xeloda Sales by Application (2016-2026)
11.3 Middle East & Africa Xeloda Market Size by Country
11.3.1 Middle East & Africa Xeloda Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Xeloda Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Xeloda Typical Distributors
12.3 Xeloda Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Xeloda Revenue by Type, (USD Million), 2021-2026
Table 2. Global Xeloda Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Xeloda Product and Services
Table 6. Roche Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Xeloda Product and Services
Table 10. Teva Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Xeloda Product and Services
Table 14. Mylan Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hikma Basic Information, Manufacturing Base and Competitors
Table 16. Hikma Major Business
Table 17. Hikma Xeloda Product and Services
Table 18. Hikma Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 20. Hengrui Medicine Major Business
Table 21. Hengrui Medicine Xeloda Product and Services
Table 22. Hengrui Medicine Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cipla Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Major Business
Table 25. Cipla Xeloda Product and Services
Table 26. Cipla Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Reliance Group Basic Information, Manufacturing Base and Competitors
Table 28. Reliance Group Major Business
Table 29. Reliance Group Xeloda Product and Services
Table 30. Reliance Group Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Hetero Basic Information, Manufacturing Base and Competitors
Table 32. Hetero Major Business
Table 33. Hetero Xeloda Product and Services
Table 34. Hetero Xeloda Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Xeloda Sales by Manufacturer (2019-2021e) & (K MT)
Table 36. Global Xeloda Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Xeloda, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Xeloda Production Capacity by Company, (K MT): 2020 VS 2021
Table 39. Head Office and Xeloda Production Site of Key Manufacturer
Table 40. Global Xeloda Sales by Region (2016-2021e) & (K MT)
Table 41. Global Xeloda Sales by Region (2021-2026) & (K MT)
Table 42. Global Xeloda Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Xeloda Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Xeloda Sales by Type (2016-2021e) & (K MT)
Table 45. Global Xeloda Sales by Type (2021-2026) & (K MT)
Table 46. Global Xeloda Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Xeloda Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Xeloda Price by Type (2016-2021e) & (USD/MT)
Table 49. Global Xeloda Price by Type (2021-2026) & (USD/MT)
Table 50. Global Xeloda Sales by Application (2016-2021e) & (K MT)
Table 51. Global Xeloda Sales by Application (2021-2026) & (K MT)
Table 52. Global Xeloda Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Xeloda Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Xeloda Price by Application (2016-2021e) & (USD/MT)
Table 55. Global Xeloda Price by Application (2021-2026) & (USD/MT)
Table 56. North America Xeloda Sales by Country (2016-2021e) & (K MT)
Table 57. North America Xeloda Sales by Country (2021-2026) & (K MT)
Table 58. North America Xeloda Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Xeloda Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Xeloda Sales by Type (2016-2021e) & (K MT)
Table 61. North America Xeloda Sales by Type (2021-2026) & (K MT)
Table 62. North America Xeloda Sales by Application (2016-2021e) & (K MT)
Table 63. North America Xeloda Sales by Application (2021-2026) & (K MT)
Table 64. Europe Xeloda Sales by Country (2016-2021e) & (K MT)
Table 65. Europe Xeloda Sales by Country (2021-2026) & (K MT)
Table 66. Europe Xeloda Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Xeloda Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Xeloda Sales by Type (2016-2021e) & (K MT)
Table 69. Europe Xeloda Sales by Type (2021-2026) & (K MT)
Table 70. Europe Xeloda Sales by Application (2016-2021e) & (K MT)
Table 71. Europe Xeloda Sales by Application (2021-2026) & (K MT)
Table 72. Asia-Pacific Xeloda Sales by Region (2016-2021e) & (K MT)
Table 73. Asia-Pacific Xeloda Sales by Region (2021-2026) & (K MT)
Table 74. Asia-Pacific Xeloda Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Xeloda Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Xeloda Sales by Type (2016-2021e) & (K MT)
Table 77. Asia-Pacific Xeloda Sales by Type (2021-2026) & (K MT)
Table 78. Asia-Pacific Xeloda Sales by Application (2016-2021e) & (K MT)
Table 79. Asia-Pacific Xeloda Sales by Application (2021-2026) & (K MT)
Table 80. South America Xeloda Sales by Country (2016-2021e) & (K MT)
Table 81. South America Xeloda Sales by Country (2021-2026) & (K MT)
Table 82. South America Xeloda Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Xeloda Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Xeloda Sales by Type (2016-2021e) & (K MT)
Table 85. South America Xeloda Sales by Type (2021-2026) & (K MT)
Table 86. South America Xeloda Sales by Application (2016-2021e) & (K MT)
Table 87. South America Xeloda Sales by Application (2021-2026) & (K MT)
Table 88. Middle East & Africa Xeloda Sales by Country (2016-2021e) & (K MT)
Table 89. Middle East & Africa Xeloda Sales by Country (2021-2026) & (K MT)
Table 90. Middle East & Africa Xeloda Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Xeloda Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Xeloda Sales by Type (2016-2021e) & (K MT)
Table 93. Middle East & Africa Xeloda Sales by Type (2021-2026) & (K MT)
Table 94. Middle East & Africa Xeloda Sales by Application (2016-2021e) & (K MT)
Table 95. Middle East & Africa Xeloda Sales by Application (2021-2026) & (K MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Xeloda Typical Distributors
Table 99. Xeloda Typical Customers
List of Figures
Figure 1. Xeloda Picture
Figure 2. Global Xeloda Sales Market Share by Type in 2020
Figure 3. 500 mg
Figure 4. 150 mg
Figure 5. Global Xeloda Sales Market Share by Application in 2020
Figure 6. Breast Cancer
Figure 7. Colorectal cancer
Figure 8. Stomach Cancer
Figure 9. Global Xeloda Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Xeloda Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Xeloda Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Xeloda Sales (2016-2026) & (K MT)
Figure 31. Global Xeloda Production Capacity (2016-2026) & (K MT)
Figure 32. Global Xeloda Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Xeloda Market Drivers
Figure 34. Xeloda Market Restraints
Figure 35. Xeloda Market Trends
Figure 36. Global Xeloda Sales Market Share by Manufacturer in 2020
Figure 37. Global Xeloda Revenue Market Share by Manufacturer in 2020
Figure 38. Xeloda Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Xeloda Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Xeloda Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Xeloda Sales Market Share by Region (2016-2026)
Figure 42. Global Xeloda Revenue Market Share by Region (2016-2026)
Figure 43. North America Xeloda Revenue (2016-2026) & (USD Million)
Figure 44. Europe Xeloda Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Xeloda Revenue (2016-2026) & (USD Million)
Figure 46. South America Xeloda Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Xeloda Revenue (2016-2026) & (USD Million)
Figure 48. Global Xeloda Sales Market Share by Type (2016-2026)
Figure 49. Global Xeloda Revenue Market Share by Type (2016-2026)
Figure 50. Global Xeloda Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Xeloda Sales Market Share by Application (2016-2026)
Figure 52. Global Xeloda Revenue Market Share by Application (2016-2026)
Figure 53. Global Xeloda Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Xeloda Sales Market Share by Country (2016-2026)
Figure 55. North America Xeloda Revenue Market Share by Country (2016-2026)
Figure 56. North America Xeloda Sales Market Share by Type (2016-2026)
Figure 57. North America Xeloda Sales Market Share by Application (2016-2026)
Figure 58. Europe Xeloda Sales Market Share by Country (2016-2026)
Figure 59. Europe Xeloda Revenue Market Share by Country (2016-2026)
Figure 60. Europe Xeloda Sales Market Share by Type (2016-2026)
Figure 61. Europe Xeloda Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Xeloda Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Xeloda Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Xeloda Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Xeloda Sales Market Share by Application (2016-2026)
Figure 66. South America Xeloda Sales Market Share by Country (2016-2026)
Figure 67. South America Xeloda Revenue Market Share by Country (2016-2026)
Figure 68. South America Xeloda Sales Market Share by Type (2016-2026)
Figure 69. South America Xeloda Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Xeloda Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Xeloda Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Xeloda Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Xeloda Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の結腸直腸がん市場規模・現状・予測（2021年-2027年） Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of …- 世界の結腸直腸がん分子診断市場規模・現状・予測（2021年-2027年） Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine…
- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の転移性結腸直腸癌手術市場規模・現状・予測（2021年-2027年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…